ARMATA PHARMACEUTICALS INC (ARMP)
US04216R1023 - Common Stock
All
Press Releases
a month ago - InvestorPlace
ARMP Stock Earnings: Armata Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
ARMP stock results show that Armata Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
10 months ago - Seeking Alpha
Armata Pharmaceuticals gets $25M in financing and new executive chief (NYSE:ARMP)
Biotechnology company focused on pathogen‐specific bacteriophage therapeutics for antibiotic‐resistant and difficult‐to‐treat bacterial infections, Armata Pharmaceuticals (ARMP) enters...
a year ago - InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth reading about on Thursday!
a year ago - Seeking Alpha
Armata stock surges 15% as inhaled bacterial drug shows promise in lung disorder patients
Armata Pharmaceuticals (ARMP) said its inhaled bacterial infection drug for lung disorder was well-tolerated with a treatment emergent adverse event ((TEAE)) profile similar to placebo...